20.213 Genome Stability and Engineering in the Context of Diseases, Drugs, and Public Health


Class Info

Studies how DNA damage leads to diseases, and how DNA repair modulates cancer risk and treatment. Also covers how DNA repair impacts genetic engineering, whether by targeted gene therapy or CRISPR-mediated genetic changes. Students gain a public health perspective by examining how DNA-damaging agents in our environment can lead to downstream cancer. Explores the underlying chemical, molecular and biochemical processes of DNA damage and repair, and their implications for disease susceptibility and treatment.

This class has 5.07, and 7.05 as prerequisites.

20.213 will not be offered this semester. It will be available in the Spring semester, and will be instructed by .

This class counts for a total of 6 credits.

You can find more information at the Bevin P. Engelward, ScD site.

MIT 20.213 Genome Stability and Engineering in the Context of Diseases, Drugs, and Public Health Related Textbooks
MIT 20.213 Genome Stability and Engineering in the Context of Diseases, Drugs, and Public Health On The Web

© Copyright 2015